Nemolizumab is a first-in-class monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signaling of IL-31. 2 IL-31 is a neuroimmune cytokine that drives itch and is ...
UK MHRA grants marketing authorization to Leo Pharma’s delgocitinib to treat adult patients with moderate to severe chronic hand eczema: United Kingdom Thursday, December 12, 20 ...